When clinic-agreement pricing breaks — replace it with pass-through

Tailor Made Compounding's pricing model flows through clinic agreements after account request approval. That can produce competitive rates for integrative and peptide-heavy clinics that commit volume to one compounder — a real strength when the relationship is stable. The cost is timing and visibility: you do not see the per-vial number in a public catalog at the moment you are quoting a patient, and re-checking a rate after formulary updates may mean another conversation with your account team rather than refreshing a cart line.

A pass-through model inverts that. With Fizy Health, the resolved 503A landed cost appears on each catalog and cart line before you check out, and the platform's margin is a disclosed facilitation fee at payment rather than an opaque per-vial markup. The drug cost is what the pharmacy charges; the platform fee is stated separately. For a clinic quoting cash-pay semaglutide, tirzepatide, or peptide refills daily, that means the price you quote and the price you pay are the same visible number, with no hidden layer inside the vial cost.

Replace Tailor Made's agreement model when the lack of upfront pricing actively slows your business. Common signals: you delay quoting a new patient because you are unsure of the current per-vial rate; you cannot confidently set cash-pay prices because landed cost is not visible at the point of sale; your formulary now spans more than one 503A partner but Tailor Made's portal only covers Tailor Made SKUs; or legacy EMR portal migration is adding friction on top of opaque pricing.

Another signal is operational, not just financial: if paid orders get rejected after payment for SIG or licensure issues, the pricing question compounds with a validation gap. A pass-through platform like Fizy Health pairs visible per-vial cost with pre-submit cart validation, so the same workflow that shows your margin also catches the errors that cost you a refund cycle. If none of these signals apply — Tailor Made SKUs cover your menu and your agreement rates are strong — clinic-agreement pricing may still be the right fit. Replace it when the model, not the compounder, is the constraint.